Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1

Table 1 Association of RHBDD1 expression with clinicopathologic parameters of NSCLC patients

Clinical pathologic parameters	Total (n = 56)	Expression of RHBDD1		p-value
Clinical pathologic parameters	Total (n = 56)	High (n = 35)	Low (n = 21)	(chi-square test)
Sex				0.0937
Male	37	26	11
Female	19	9	10
Age				0.5343
< 60	27	18	9
≥ 60	29	17	12
Tumor size (cm)				0.2035
< 4	22	16	6
≥ 4	34	19	15
TNM stage				0.0008
I + II	35	16	19
III + IV	21	19	2
Lymph node metastasis				0.0006
Yes	37	29	8
No	19	6	13

Note: The bold values indicates the P values which are less than 0.05
Abbreviations: NSCLC Non-small cell lung cancer, TNM Tumor-node-metastasis classification system

ISSN: 1689-1392